MedPath
NMPA Approval

Cefaclor for Suspension

国药准字HJ20150070

January 15, 2024

H20150070

Drug Information

头孢克洛干混悬剂

乐维

口服混悬剂

125mg/5ml(按C₁₅H₁₄ClN₃O₄S计算)

化学药品

January 15, 2024

January 14, 2029

Company Information

Applicant Company

Industrial Area No. 3 A.B. Road, Dewas 455 001 (MP), INDIA

Manufacturing Company

Industrial Area No. 3 A.B. Road, Dewas 455 001 (MP), INDIA

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

头孢克洛干混悬剂 - NMPA 批准文号 | MedPath